Anusaksathien O, Laplace C, Li X, Ren Y, Peng L, Goldring S R, Galson D L
New England Baptist Bone and Joint Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA.
J Biol Chem. 2001 Jun 22;276(25):22663-74. doi: 10.1074/jbc.M007104200. Epub 2001 Apr 17.
The gene encoding the murine calcitonin receptor (mCTR) was isolated, and the exon/intron structure was determined. Analysis of transcripts revealed novel cDNA sequences, new alternative exon splicing in the 5'-untranslated region, and three putative promoters (P1, P2, and P3). The longest transcription unit is greater than 67 kilobase pairs, and the location of introns within the coding region of the mCTR gene (exons E3-E14) are identical to those of the porcine and human CTR genes. We have identified novel cDNA sequences that form three new exons as well as others that add 512 base pairs to the 5' side of the previously published cDNA, thereby extending exon E1 to 682 base pairs. Two of these novel exons are upstream of exon E2 and form a tripartite exon E2 (E2a, E2b, and E2c) in which E2a is utilized by promoter P2 with variable splicing of E2b. The third new exon (E3b') lies between E3a and E3b and is utilized by promoter P3. Analysis of mCTR mRNAs has revealed that the three alternative promoters give rise to at least seven mCTR isoforms in the 5' region of the gene and generate 5'-untranslated regions of very different lengths. Analysis by reverse transcription-polymerase chain reaction shows that promoters P1 and P2 are utilized in osteoclasts, brain, and kidney, whereas promoter P3 appears to be osteoclast-specific. Using transiently transfected reporter constructs, promoter P2 has activity in both a murine kidney cell line (MDCT209) and a chicken osteoclast-like cell line (HD-11EM), whereas promoter P3 is active only in the osteoclast-like cell line. These transfection data confirm the osteoclast specificity of promoter P3 and provide the first evidence that the CTR gene is regulated in a tissue-specific manner by alternative promoter utilization.
分离出编码小鼠降钙素受体(mCTR)的基因,并确定了外显子/内含子结构。转录本分析揭示了新的cDNA序列、5'-非翻译区新的可变外显子剪接以及三个推定的启动子(P1、P2和P3)。最长的转录单位大于67千碱基对,mCTR基因编码区(外显子E3-E14)内内含子的位置与猪和人CTR基因的相同。我们鉴定出形成三个新外显子的新cDNA序列以及其他在先前发表的cDNA 5'侧增加512个碱基对的序列,从而将外显子E1延伸至682个碱基对。其中两个新外显子位于外显子E2上游,形成一个三联体外显子E2(E2a、E2b和E2c),其中E2a由启动子P2利用,E2b可变剪接。第三个新外显子(E3b')位于E3a和E3b之间,由启动子P3利用。mCTR mRNA分析表明,这三个可变启动子在基因的5'区域产生至少七种mCTR异构体,并产生长度差异很大的5'-非翻译区。逆转录-聚合酶链反应分析表明,启动子P1和P2在破骨细胞、脑和肾中被利用,而启动子P3似乎是破骨细胞特异性的。使用瞬时转染的报告构建体,启动子P2在小鼠肾细胞系(MDCT209)和鸡破骨细胞样细胞系(HD-11EM)中均有活性,而启动子P3仅在破骨细胞样细胞系中有活性。这些转染数据证实了启动子P3的破骨细胞特异性,并提供了第一个证据表明CTR基因通过可变启动子利用以组织特异性方式受到调控。